MAHWAH, N.J., Nov. 15, 2018 /PRNewswire/ — Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company is presenting new data for for its leading respiratory pipeline candidate Ryaltris (rye – al' – tris)…Original Article
You may also like
Scientists Race to Test Treatments as Ebola Outbreak...
The New Race to Find Treatments for Measles
Medical Advances Are Keeping a Health Reporter Busy
As Ebola Spreads, Scientists Race to Find Vaccines and...
Shortage of Chemotherapy Drugs Brings Rationing Fears...
A Loophole Brings Cystic Fibrosis Patients a...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
